FCGR1A and acute promyelocytic leukemia: The area under the curve (AUC) was 0.970 with a 95% CI: 0.958−0.982 (P < 0.0001), which demonstrates a near perfect performance of relative quantification of CD64 marker in differentiating APL from non-APL/M5 patients.